NASDAQ:HX Hexindai Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Hexindai Inc - Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.52 +0.07 (+4.83 %) (As of 09/28/2020 12:00 AM ET) Add Compare Share Today's Range$1.46Now: $1.52▼$1.6150-Day Range$0.62MA: $1.39▼$1.9552-Week Range$0.76Now: $1.52▼$7.44Volume24,929 shsAverage Volume483,904 shsMarket Capitalization$26.58 millionP/E RatioN/ADividend YieldN/ABeta1.33 ProfileChartCompetitorsDividendEarningsInstitutional OwnershipHeadlinesShort InterestSocial Media Hexindai Inc. operates a consumer lending marketplace that facilitates loans in China. It primarily focuses on facilitating medium-sized credit loans. The company provides borrowers a range of products based on customer segmentation data and tailored to the specific needs of the emerging middle class; and investors various types of investment products. The company was founded in 2013 and is headquartered in Beijing, China.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Hexindai. Previous Next 2.3 Community Rank Outperform VotesHexindai has received 262 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHexindai has received 311 “underperform” votes. (Add your “underperform” vote.)Community SentimentHexindai has received 54.28% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Hexindai and other stocks. Vote “Outperform” if you believe HX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHexindai does not currently pay a dividend.Dividend GrowthHexindai does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hexindai insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 8.82% of the stock of Hexindai is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Hexindai is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hexindai is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHexindai has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.59 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Nondepository credit institutions Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:HX Previous Symbol CUSIPN/A CIKN/A Webwww.hexindai.com Phone86-10-5370-9902Debt Debt-to-Equity Ratio0.42 Current Ratio4.91 Quick Ratio4.91Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$11.44 million Price / Sales2.32 Cash FlowN/A Price / Cash FlowN/A Book Value$2.75 per share Price / Book0.55Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees400 Outstanding Shares17,485,000Market Cap$26.58 million Next Earnings Date9/30/2020 (Estimated) OptionableNot Optionable $1.52 +0.07 (+4.83 %) (As of 09/28/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive HX News and Ratings via Email Sign-up to receive the latest news and ratings for HX and its competitors with MarketBeat's FREE daily newsletter. Hexindai (NASDAQ:HX) Frequently Asked Questions How has Hexindai's stock price been impacted by Coronavirus? Hexindai's stock was trading at $0.3663 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HX shares have increased by 315.0% and is now trading at $1.52. View which stocks have been most impacted by COVID-19. When is Hexindai's next earnings date? Hexindai is scheduled to release its next quarterly earnings announcement on Wednesday, September 30th 2020. View our earnings forecast for Hexindai. How were Hexindai's earnings last quarter? Hexindai Inc - (NASDAQ:HX) posted its quarterly earnings data on Friday, June, 15th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.29 by $0.03. The business earned $27.61 million during the quarter. View Hexindai's earnings history. Are investors shorting Hexindai? Hexindai saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 15,800 shares, a decline of 46.1% from the August 31st total of 29,300 shares. Based on an average daily volume of 587,400 shares, the short-interest ratio is currently 0.0 days. View Hexindai's Short Interest. Who are some of Hexindai's key competitors? Some companies that are related to Hexindai include Elevate Credit (ELVT), Velocity Financial (VEL), On Deck Capital (ONDK), X Financial (XYF), Consumer Portfolio Services (CPSS), Fincera (YUANF), Golden Bull (BTBT), Weidai (WEI), Medallion Financial (MFIN), Golden Bull (DNJR), Mogo Finance Technology (MOGO), Senmiao Technology (AIHS), Harvest Capital Credit (HCAP), China Rapid Finance (XRF) and China YiBai United Guarantee International (CBGH). View all competitors. What other stocks do shareholders of Hexindai own? Based on aggregate information from My MarketBeat watchlists, some companies that other Hexindai investors own include Gran Tierra Energy (GTE), Cannabics Pharmaceuticals (CNBX), Pennsylvania R.E.I.T. (PEI), OrganiGram (OGI), BioNano Genomics (BNGO), CBL & Associates Properties (CBL), Auxly Cannabis Group (CBWTF), Matinas BioPharma (MTNB), Novan (NOVN) and ADMA Biologics (ADMA). Who are Hexindai's key executives? Hexindai's management team includes the following people: Mr. Xiaobo An, Chairman (Age 37)Mr. Xinming Zhou, CEO & Director (Age 35)Mr. Qisen Zhang, Chief Financial Officer (Age 36)Ms. Lili Hua, Chief Operations Officer (Age 34)Ms. Daisy Wang, Investor Relation Contact What is Hexindai's stock symbol? Hexindai trades on the NASDAQ under the ticker symbol "HX." Who are Hexindai's major shareholders? Hexindai's stock is owned by many different retail and institutional investors. Top institutional investors include Two Sigma Advisers LP (0.36%) and Virtu Financial LLC (0.07%). Which institutional investors are selling Hexindai stock? HX stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP. Which institutional investors are buying Hexindai stock? HX stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC. How do I buy shares of Hexindai? Shares of HX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Hexindai's stock price today? One share of HX stock can currently be purchased for approximately $1.52. How big of a company is Hexindai? Hexindai has a market capitalization of $26.58 million and generates $11.44 million in revenue each year. Hexindai employs 400 workers across the globe. What is Hexindai's official website? The official website for Hexindai is www.hexindai.com. How can I contact Hexindai? Hexindai's mailing address is 5TH FLOOR BLOCK C SHIMAO NO. 92 JIANGUO ROAD CHAOYANG DIST, BEIJING F4, 100000. The company can be reached via phone at 86-10-5370-9902 or via email at [email protected] This page was last updated on 9/28/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
